Avenir Wellness Solutions™ ($AVRW) Skin Care Products are Sold at Major Retailers Including Walmart $WMT, Target $TGT, CVS Health $CVS, and Amazon $AMZN.
Avenir Wellness Solutions, Inc. (OTCMKTS:AVRW)
SHERMAN OAKS, CALIFORNIA, UNITED STATES , November 16, 2023 /EINPresswire.com/ — Increasingly Positive Fundamentals Reported for Marketer of Best Performing Skin Care Line with Endorsements by Nicole Kidman and Top Plastic Surgeon: Avenir Wellness Solutions, Inc. (Stock Symbol: AVRW)
Avenir Wellness Solutions™ ($AVRW) Skin Care Products are Sold at Major Retailers Including Walmart ($WMT), Target ($TGT), CVS Health ($CVS), and Amazon ($AMZN)
For more information on Avenir Wellness Solutions ($AVRW) visit: www.avenirwellness.com
Proprietary Nutraceutical & Topical Delivery Systems for Wellness and Anti-Aging Beauty Product Lines.
Company Currently Holds 15 Patents.
Seratopical Revolution Skin Care Products Promoted by the Company’s Global Brand Ambassador and Strategic Partner Nicole Kidman.
Latest Media Exposure in Top-Tier Publications Including CNN Underscored, Page Six, PEOPLE Magazine and More.
Q3 Net Revenue Increased Sequentially from Q2 2023.
Sales Expected to Increase During Q4 and Into 2024.
Gross Margin Increased 80 Basis Points Quarter-to-Quarter with Further Expansion Expected in Q4.
Upcoming Launch of New Beauty Product Releases & New Marketing Initiatives.
New Partnership with LA-Based Facial Plastic Surgeon Dr. Michael Persky to Support Latest DNA Complex Product Launch.
Latest Sales Results Show Accelerating Strength via New Marketing Campaigns.
Avenir Wellness (OTCQB: AVRW) is a broad platform technology company that develops proprietary wellness, nutraceutical, and topical delivery systems. The technology, which is based on 15 current patents, offers a number of unique immediate- and controlled-release delivery vehicles designed to improve product efficacy, safety, and consumer experience for a wide range of active ingredients. As a vertically integrated platform company, Avenir Wellness (AVRW) looks to partner or license its IP technology with wellness companies worldwide.
Sera Labs, a wholly owned subsidiary of Avenir Wellness (AVRW), creates high-quality products that use science-backed, proprietary formulations. Products are sold under the brand names Seratopical™, Seratopical Revolution™, SeraLabs™, and Nutri-Strips™. Avenir Wellness (AVRW) Sera Labs products are sold direct-to-consumer (DTC) via online website orders, including opt-in subscriptions, and also sold online and in-store at major national drug, grocery chains, convenience stores, and mass retailers including Walmart, CVS and Target as well as on the Amzon.com platform.
Avenir Wellness (AVRW) has a current focus on the beauty and wellness markets which are growing at rapid rates. The global wellness sector, despite the pandemic, saw exponential growth in 2021 with a market size of $1.5 trillion, according to McKinsey. There is a strong overall and growing demand for supplements and nutraceuticals, a $587.3 billion market, according to the 2021 Grandview report. The beauty and personal care industry is a $534 billion market now and is set to grow 5.87% year over year according to Terakeet’s 2021 Beauty Industry Report.
Nicole Kidman is the Global Brand Ambassador of Avenir Wellness Seratopical Revolution Product Line
Avenir Wellness (AVRW) is represented by the famous Nicole Kidman as a Strategic Partner and Global Brand Ambassador.
The story of Nicole Kidman’s involvement with Avenir Wellness (AVRW) is detailed on the Company’s website here: https://seralabshealth.com/pages/about and is also described in a recent interview with Avenir Wellness (AVRW) CEO Nancy Duitch on the well followed “New to the Street” Investment program. The interview can be watched at this link: https://www.youtube.com/watch?v=LuBto12YZmc.
To highlight Breast Cancer Awareness Month in October, Avenir Wellness (AVRW) has launched a limited edition Think Pink bundle. In honor of Nicole Kidman, and her ongoing support of the Vanderbilt-Ingram Cancer Center, a portion of proceeds from each bundle sold will be donated to support this worthy cause.
See Nicole Kidman’s inspiring personal video and ordering information here: https://seralabshealth.com/products/think-pink
Avenir Wellness (AVRW) continues to receive high profile media attention with exposure for the company’s Seratopical Revolution product line. Avenir Wellness (AVRW) was able to secure coverage in top-tier publications, including CNN Underscored, Page Six, PEOPLE Magazine and more. These placements garnered over 513M media impressions for the increasingly popular and successful Avenir Wellness (AVRW) Seratopical Revolution brand.
Some examples of the latest Avenir Wellness (AVRW) media exposure may be seen at the following links:
Image 9-1-23 at 2.14 PM (1) 1.jpeg
Positive Q3 Results with New Campaigns Showing Encouraging Results
On November 14th AVRW announced results for the third fiscal quarter ended September 30, 2023.
Key financial highlights for the second quarter included the following:
Avenir Wellness (AVRW) net revenue in the third quarter of 2023 increased sequentially from Q2 2023 to $1.0 million but decreased year-over-year due to the delay in receiving the expected remainder of the asset sale proceeds. Sales are expected to increase during the fourth quarter and into 2024.
Gross margin increased 80 basis points quarter-to-quarter with further expansion expected in the fourth quarter of 2023 with an increase in higher margin direct-to-consumer sales and the launch of our new beauty product releases as well as our new marketing initiatives.
Gross margin for the third quarter decreased by 740 basis points to 72.6% in 2023 compared to the same period in 2022 due to a shift in sales channel mix with a higher proportion of wholesale sales to Amazon and Walmart which have benefitted in 2023 from our advertising initiatives.
SG&A expenses (excluding non-cash charges) for the third quarter decreased by $721 thousand in 2023 compared to 2022 driven by increased spend on advertising and promotion of $74 thousand, offset in part by lower overhead by $795 thousand.
Net operating loss from continuing operations (excluding non-cash charges) improved by $30 thousand in 2023. Cost reductions and operating leverage are expected to help narrow the operating loss (excluding non-cash charges) in the fourth quarter.
Avenue Wellness (AVRW) CEO Nancy Duitch stated, “Our products continue to maintain sales levels which is encouraging given that we have been unable to fully execute on our marketing initiatives pending receipt of the balance of the proceeds from the July 2022 asset sale. As mentioned in our second quarter earnings announcement, the proceeds from the July 2022 asset sale allow us to invest in the future of the Company, but the delay in receiving the balance of the proceeds continued to have an impact on our operating performance. We expect accelerating sales will reaffirm the improving overall trajectory of the business. Further, our margin expansion initiatives continue to deliver results with improvement from second quarter, and we are moving forward with our efforts to further reduce SG&A expenses and to maximize operating leverage. Fine tuning our SEO and successful monthly campaigns like theSkimm continue to deliver as we execute on our strategy to build our brands”
Avenir Wellness (AVRW) new beauty subscription program has grown sequentially by 50% quarter over quarter.
The DNA Complex hero product continues to perform as its subscription based grows.
Wholesale sales led by Amazon and Walmart continue to grow with all the positive product reviews. Amazon was a particular bright spot with volume growth despite retail price increases to match our ecommerce site which increased margins to 85%.
Partnership with LA-Based Facial Plastic Surgeon Dr. Michael Persky to Support Latest DNA Complex Product Launch
On September 12th Avenir Wellness (AVRW) announced that renowned plastic surgeon Dr. Michael A. Persky, M.D., F.A.C.S., will help support marketing for the latest launches and advise on new product innovation.
This partnership for Avenir Wellness (AVRW) came about through a long-standing relationship with Nancy Duitch, CEO and Founder of Sera Labs. Dr. Persky will support brand marketing, social, and advertising campaigns for the Avenir Wellness (AVRW) brand’s latest innovation, patent-pending DNA (Deep Nano Actives) Complex, an instant anti-aging skin tightening serum that penetrates deep into the skin. As an advisory board member, Dr. Persky will also advise on formulating the brand’s future plant-based and scientifically grounded products.
DISCLAIMER: CAP/FrontPageStocks/CorporateAds.com (CA) is a third-party publisher and news dissemination service provider. CAP/FPS/CA is NOT affiliated in any manner with any company mentioned herein. CAP/FPS/CA is a news dissemination solutions provider and is NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. CAP/FPS/CA’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release or opinion of the writer. CAP/FPS/ CA is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. CAP/FPS/CA has been compensated $500 by a third party for dissemination of this article.
These news releases and postings may contain forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.